Johnson & Johnson

SwipeRx is a digital platform designed to enhance the operations of pharmacies by connecting pharmaceutical manufacturers, pharmacies, and patients. It offers a range of services, including specialized healthcare logistics, negotiated pricing, and financing solutions, creating a robust network for pharmacy purchasing. The platform generates insights that facilitate collaboration with pharmacies, improve pharmacist education, and strengthen market access. Additionally, it optimizes commercial strategies and enhances daily operational efficiencies. By providing real-time access to patient and sell-out data, SwipeRx enables its clients to improve patient affordability, access, and adherence to medications.

Lucia Health Guidelines develops a clinical decision support tool that utilizes cloud computing and machine learning to enhance adherence to clinical guidelines at the point of care. The primary focus of the company's platform is to improve the diagnosis and treatment of Atrial Fibrillation (AFib) within Emergency Departments. By providing clinicians with effective tools to accurately identify AFib, the technology facilitates the initiation of guideline-recommended treatments aimed at preventing strokes. This approach not only aims to save lives and improve patient outcomes but also seeks to lower overall healthcare costs by promoting adherence to established medical recommendations.

TQIntelligence, Inc. operates a platform that measures emotional distress severity through voice-based artificial intelligence technology. Founded in 2016 and headquartered in Atlanta, Georgia, the company integrates various data sources to provide cognitive insights into risk stratification, treatment outcomes, and personalized behavioral health interventions. Its key products include TQ-Intelligence, which utilizes voice and speech analytics alongside psychometrically sound instruments, and TQ Analytics, which leverages existing electronic medical record data to deliver actionable insights. TQIntelligence's machine learning analytics and real-time prediction capabilities support therapists in diagnosing mental health issues, particularly for children and adolescents, including those from BIPOC and LGBTQ communities. By focusing on voice biomarkers, the company aims to enhance treatment planning and reduce care costs while improving outcomes in the behavioral healthcare sector.

Patient Orator is a mental health company that focuses on enhancing communication between marginalized communities and healthcare providers through its mobile application. The platform utilizes storytelling to create a safe digital environment where users can openly discuss their health concerns and social needs without fear of judgment or bias. By emphasizing preventative medicine and shared decision-making, Patient Orator aims to improve patient experiences and overall population health. The application is designed to ensure that individuals from diverse backgrounds, regardless of race, ethnicity, gender, nationality, or insurance status, have better access to essential healthcare resources.

AYANA is a telehealth platform that offers access to mental therapy to marginalized communities by enabling virtual communication with licensed therapists through a smart matchmaking algorithm based on their cultural experiences and identity traits. Our aim is to address the severe lack of access to mental health services by people of color & LGBTQ+ communities in an effort to combat the high cost, stigma, and the poor cultural competency by the health care industry.

Radical Health is a healthcare technology company focused on promoting health equity through meaningful conversations and community engagement. By leveraging AI-enabled technology, Radical Health helps individuals better understand their health during medical visits, fostering trust and self-advocacy. The company offers workshops and training that facilitate deeper discussions around the social determinants of health for both community members and healthcare providers. In addition, Radical Health features Radical Relay, an AI-based chat application designed to empower individuals with knowledge of their rights throughout pregnancy. Through its innovative approach, Radical Health aims to equip and empower people to actively advocate for themselves within the healthcare system.

Momenta Pharmaceuticals, Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of therapeutics for rare immune-mediated diseases. The company's innovative drug pipeline includes M281, a monoclonal antibody designed to reduce circulating IgG antibodies, M254, a treatment for various inflammatory diseases, and M230, a recombinant multimer aimed at enhancing therapeutic activity. Momenta also has biosimilars in development, including M923, a biosimilar of HUMIRA for autoimmune conditions, and M710, a biosimilar of EYLEA for eye-related diseases. Additionally, the company offers complex generics, such as Enoxaparin sodium injection, a generic version of LOVENOX, and GLATOPA, a generic form of COPAXONE for multiple sclerosis. While Momenta previously engaged in the development of generics and biosimilars, it has shifted focus towards innovative drug development. The company has established collaboration agreements with several partners in the pharmaceutical industry.

Verb Surgical Inc. is a company that develops a digital surgery platform aimed at transforming surgical procedures. Established in 2015 and headquartered in Santa Clara, California, the company focuses on integrating robotics, advanced visualization, sophisticated instrumentation, data analytics, and connectivity to enhance the capabilities of operating room professionals. By leveraging these technologies, Verb Surgical seeks to improve patient outcomes and reduce the overall cost of care, making surgical procedures more accessible and efficient. As a subsidiary of Johnson & Johnson Innovation - JJDC, Inc., Verb Surgical aims to democratize surgery through its innovative platform.

TARIS Biomedical, Inc. is a therapeutically focused urology company based in Lexington, Massachusetts, established in 2008. The company specializes in developing innovative treatments for challenging bladder diseases, including bladder cancer and overactive bladder. TARIS's unique drug delivery system allows for the continuous release of medications within the bladder over extended periods, ranging from weeks to months. This system is designed to be deployed and retrieved through minimally invasive, in-office procedures, enabling a tailored approach to drug release that meets the specific needs of various bladder conditions. As of December 2019, TARIS Biomedical operates as a subsidiary of Janssen Research & Development, LLC.

KnowRX is a developer of a cloud-based digital healthcare platform designed to enhance therapeutic care by facilitating patient and physician engagement. The platform employs machine learning technology, known as Maestro ML™, to create personalized care pathways that support clinical trial participation, improve medication adherence, and promote daily wellness activities across nutritional, psychological, and physical domains. It provides healthcare providers and patients with critical drug information, current clinical trial updates, and resources for selecting appropriate therapies. Additionally, the platform offers access to counseling, genomic data for treatment compatibility, nutritional guidance, and instructional content on clinical research. By streamlining communication between patients and healthcare professionals, KnowRX aims to optimize treatment outcomes and empower patients in their self-care journeys.

Tiny Hearts provides production and deployment of phototherapy treatment essentials, procurement and supply of other medical equipment and disposables to hospitals. Their customers inquiries are addressed through phone, email, and online applications.

Uganics is an organization providing organic mosquito repellent products including soaps, candles, lotion bars, and essential oils. Uganics produces an affordable and long-lasting organic mosquito repellent soap that helps mothers with children below the age of five in rural communities to prevent mosquito bites.

M-Scan is a medical device company focused on developing portable mobile ultrasound devices specifically designed for pregnant mothers. The company aims to improve maternal and neonatal health by leveraging smart device technology to facilitate early detection and management of risks associated with maternal and neonatal mortality. By providing these innovative ultrasound solutions, M-Scan seeks to enhance the quality of life for mothers and their children, particularly in resource-limited settings where access to traditional healthcare may be challenging.

DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.

Oncochain is focused on creating a real-world data platform tailored for oncology, aimed at standardizing and aggregating anonymized data from cancer patients. This platform generates valuable analytics that support pharmaceutical research and enhance value-based care for healthcare providers. Utilizing a web-based oncology-specific electronic health record, Oncochain develops operational data repositories that streamline the information flow between providers and enhance the skills of oncology professionals. The platform significantly aids research by reducing the time required for patient recruitment in clinical trials and establishing a framework for multi-centric study design and implementation. Through its SaaS analytics tool, Oncochain provides critical real-world data insights to clients, including pharmaceutical companies and contract research organizations, ultimately contributing to improved outcomes in oncological care and accelerating research efforts.

Auris Health, Inc., based in Redwood City, California, develops innovative robotic technology for medical applications, particularly in the field of endoscopy. The company is known for its Monarch Platform, which facilitates diagnostic and therapeutic bronchoscopic procedures by utilizing small cameras and tools that access the body through natural openings. In addition to endoscopic applications, Auris Health is creating a novel dual-arm microsurgical system aimed at enhancing ophthalmic surgery. By integrating advancements in imaging technology, robotics, micro-instrumentation, and data science, Auris Health seeks to transform medical interventions, ultimately improving patient outcomes and reducing costs. Founded in 2007, the company operates as a subsidiary of Johnson & Johnson.

Ci:z Holdings Co., Ltd. is a Japan-based company engaged in the development, manufacturing, and sale of cosmetics, health foods, and beauty care products. Founded in 1999 and headquartered in Tokyo, the company operates primarily through two business segments: cosmetics and health food. The cosmetics segment offers a diverse range of products, including functional and gentle cosmetics designed for various skin issues, under brand names such as Dr.Ci:Labo, Labo Labo, and Genomer. The health food segment provides nutritional supplements and food products aimed at enhancing health and beauty from within. Ci:z Holdings markets its products through multiple channels, including direct mail order, wholesale to drug stores and cosmetics shops, and its own retail locations in department stores and shopping centers. The majority of the company's revenue is generated in the domestic market, with a growing presence internationally, including in Taiwan, Hong Kong, and the United States.

Zarbee's, Inc. specializes in the manufacture and sale of cough and throat relief products, immune support items, and vitamins and supplements for both children and adults. Founded in 2007 and headquartered in Draper, Utah, the company provides its products through various retail and online channels. Zarbee's is known for its commitment to natural health solutions and offers clinically proven health tips and advice for families. Additionally, it maintains a location in Greenwich, Connecticut. As of September 2018, Zarbee's operates as a subsidiary of Johnson & Johnson Consumer Inc.

Cue helps users track their health at the molecular level, revealing the interplay of activity, food, and sleep. Consumers can track five key health and lifestyle indicators: inflammation, vitamin D, fertility, influenza, and testosterone in just minutes, at home. The Cue sends the data via Bluetooth 4.0 to the user's smartphone, where the free Cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level.

Dreem is a neurotechnology company building consumer technology that stimulates the brain to enhance human potential. The company's product, Dreem is a wearable device that enhances the quality of deep sleep. The device monitors brainwaves, analyzes user's sleep and stimulates the brain with sound in order to extend the amount of deep sleep, improving human performance throughout the day.

Orthotaxy is a medical technology company based in Gières, France, specializing in software-enabled surgery solutions for the healthcare industry. The company focuses on designing and developing computer-assisted platforms that enhance surgical procedures. With a team of qualified engineers, Orthotaxy creates innovative medical devices that are subject to rigorous quality assurance processes. This approach allows healthcare providers to personalize surgical procedures and optimize outcomes for patients.

Bloomlife is a women's health company focused on addressing critical challenges in maternal health through an innovative remote care platform. By integrating connected devices with cloud-based data analytics, Bloomlife enhances access to care and empowers expectant mothers while providing clinicians with essential information to better screen and manage pregnancy complications. The company's prenatal wearable technology is designed to assess fetal health, enabling the identification of potential complications that could lead to serious outcomes such as brain damage or stillbirth. This approach marks a significant departure from traditional methods of managing high-risk pregnancies, which often involve frequent in-person appointments and lengthy referral processes. Bloomlife aims to be a leader in remote maternal care, facilitating timely interventions and support for women, regardless of geographic barriers.

Prapela is a company that offers noninvasive stimulation therapy designed to enhance the health of newborns, specifically targeting issues such as irregular breathing and low oxygenation. By placing a reusable pad inside a hospital bassinet or incubator, Prapela provides gentle stimulation that supports the natural processes of breathing control and oxygenation. This therapy aims to improve cardiorespiratory outcomes while reducing the need for pharmacotherapy and minimizing the duration of conventional treatments for severe medical conditions. Since its inception, Prapela has garnered significant recognition as a leading pediatric medical device startup, receiving multiple awards and over $8 million in grants. The company collaborates with neonatologists, the National Institutes of Health, and the FDA to develop and refine its solutions, contributing to better health outcomes for newborns.

DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.

Actelion Ltd is a Swiss biopharmaceutical company dedicated to the discovery, development, and commercialization of low molecular weight drugs aimed at addressing various medical conditions. The company primarily focuses on treatments for pulmonary arterial hypertension (PAH) and offers several products, including Tracleer, Opsumit, Uptravi, Ventavis, and Veletri, which target different stages of the disease through various administration methods. Actelion also markets Zavesca, a treatment for type 1 Gaucher disease, and Valchlor, which is used for a rare form of blood cancer. To enhance its product pipeline, Actelion has engaged in in-licensing and acquisitions. The company has established a global commercial infrastructure for its approved orphan drugs and continues to evaluate new compounds in clinical development for a range of diseases, including cardiovascular, immunological, infectious, and central nervous system disorders. Founded in 1997, Actelion is headquartered in Allschwil, Switzerland.

RayIoT Solutions Inc. specializes in developing innovative monitoring devices designed for health and safety. One of its flagship products, Raybaby, is a sophisticated baby monitor that tracks a child's respiration and sleep patterns, providing alerts for elevated respiratory rates that may indicate fever or other health issues. Equipped with an infrared video camera, Raybaby allows for live video streaming in complete darkness, along with built-in speakers and audio monitoring through a highly sensitive microphone. In addition, the company offers a wall-mounted monitoring device that transforms any space into a mini intensive care unit, continuously monitoring breathing rates and enabling the early detection of respiratory distress for patients in self-quarantine or quarantine facilities.

Neurotrack is a digital health company focused on transforming the diagnosis and management of Alzheimer's and other dementias. Founded in 2012 by Elli Kaplan and neuroscientist Dr. Stuart Zola, the company is headquartered in Redwood City, California. Neurotrack develops user-friendly, clinically validated cognitive assessments that can be administered in clinical settings or at home, allowing for early detection of cognitive impairment and ongoing monitoring of cognitive function. The company's solutions are designed to fit seamlessly into various workflows, enabling healthcare providers to efficiently screen patients for cognitive decline and take necessary next steps. Neurotrack has published 27 peer-reviewed papers, holds 11 patents for its proprietary technology, and is registered as an FDA Class II medical device.

Abbott is a global healthcare company engaged in the development and marketing of a diverse range of products, including cardiovascular and diabetes devices, nutritional products for adults and children, diagnostic equipment, and branded generic pharmaceuticals. The company is recognized for its leadership in molecular diagnostics through Abbott Molecular, which focuses on DNA, RNA, and protein analysis, facilitating early disease diagnosis and treatment selection. Abbott’s extensive product portfolio features items such as pacemakers, implantable cardioverter defibrillators, continuous glucose monitors, and various diagnostic testing kits. With a significant portion of its sales generated outside the United States, Abbott is committed to providing high-quality healthcare solutions, including those targeting women's health, gastroenterology, cardiology, and metabolic disorders. In India, Abbott India Limited, a subsidiary of Abbott Laboratories, continues to enhance health outcomes through science-based products.

Ci:z Holdings Co., Ltd. is a Japan-based company engaged in the development, manufacturing, and sale of cosmetics, health foods, and beauty care products. Founded in 1999 and headquartered in Tokyo, the company operates primarily through two business segments: cosmetics and health food. The cosmetics segment offers a diverse range of products, including functional and gentle cosmetics designed for various skin issues, under brand names such as Dr.Ci:Labo, Labo Labo, and Genomer. The health food segment provides nutritional supplements and food products aimed at enhancing health and beauty from within. Ci:z Holdings markets its products through multiple channels, including direct mail order, wholesale to drug stores and cosmetics shops, and its own retail locations in department stores and shopping centers. The majority of the company's revenue is generated in the domestic market, with a growing presence internationally, including in Taiwan, Hong Kong, and the United States.

Vogue International is one of America’s manufacturer and distributor of salon-heritage hair care and other personal care products. For over 20 years, Vogue has represented a refreshing and innovative point of difference in a saturated hair care industry. Headquartered in Tampa Bay, Florida, Vogue’s branded products include the FX™ line of hair styling products, the award winning OGX® collection of shampoos, conditioners and styling/treatment items, and OGX® Bath & Body Collection. Vogue’s products are distributed exclusively to the world’s largest retailers, primarily through the Food, Drug, and Mass channels of distribution, both domestically throughout the U.S. and globally in 42 foreign countries. The FX™ line of styling products has been an industry leader in new innovation and state of the art technology and continues its amazing success after thirteen years of representation. FX™ is one of America’s top salon inspired brands. Each FX™ product is enriched with the best ingredients, specially selected to give your hair the care it needs to look sexy, styled and healthy every day. OGX® Hair Care is an award-winning collection of over 70 items containing shampoos, conditioners and styling/treatment products, which have been met with rave reviews by retailers and consumers alike. OGX® products contain exotic ingredients and are do not contain Sodium Laureth Sulfate or Sodium Laurel Sulfate …plus the fragrances are amazing! As the leader in the segment, OGX® furthered its commitment by jumping to the forefront of “green” packaging by being the first in the segment to change to environmental friendly components. Our philosophy of “beauty pure and simple” continues with the introduction of a luxurious Bath & Body Collection, this exotic new assortment of creamy lotions, lathering body washes, and an extra hydrating dry body oil feature an amazing moisturizing formulas AND… with a scent for everyone, the Bath & Body Collection provides the perfect complement to Their hair care favorites. “They are constantly recreating the company so They are always offering innovative products to a very savvy consumer,” states Todd Christopher, Vogue’s Founder. “Customers can always look to us for the most advanced beauty products on the market today”, continued Christopher. Through a strong management team, a unique blend of innovation, creativity, technology, skilled dedicated employees, and strong processes, Vogue is able to consistently set the standard of introducing exciting new products that are inherently in touch with the consumers’ demand for salon quality, innovation, and performance, while creating and identifying current and emerging trends.

Suncayr has developed a colour changing sticker that tells you when your sunscreen is no longer protecting you. The sticker, "SPOT", is is put directly on the skin, and then sunscreen is applied to your whole body. When your sunscreen is protecting your skin from UV, the sticker is clear, but when your skin becomes exposed to UV, the sticker changes to purple. This will give you and your family the confidence to safely enjoy the sun!

Tesaro, Inc. is an oncology-focused biopharmaceutical company established in 2010 and headquartered in Waltham, Massachusetts. The company is dedicated to developing and commercializing cancer therapeutics and supportive care products. Its primary offerings include ZEJULA, a potent oral poly polymerase inhibitor for the maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer, and VARUBI, a neurokinin-1 receptor antagonist designed to prevent chemotherapy-induced nausea and vomiting. Additionally, Tesaro is engaged in the development of several immunotherapy antibody candidates, including TSR-042, TSR-022, and TSR-033, all currently in phase I clinical trials. The company collaborates with various organizations, such as AnaptysBio, Janssen Biotech, and Merck Sharp & Dohme, to enhance its research and development efforts. Tesaro aims to leverage its management team's expertise to identify and commercialize innovative treatments that improve the lives of cancer patients. As of January 2019, Tesaro operates as a subsidiary of GlaxoSmithKline.

Novira Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Doylestown, Pennsylvania, focused on discovering and developing antiviral drugs for chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) infections. The company specializes in creating first-in-class oral therapeutics that target the capsid of these viruses, offering potential treatment options that address significant limitations in current therapies. Novira's innovative capsid inhibitors can be used alone or in conjunction with existing treatments, aiming to overcome challenges such as drug resistance and the need for lifelong therapy, particularly in chronic HBV infection, where existing polymerase inhibitors are rarely curative. Founded in 2006, Novira Therapeutics operates as a subsidiary of Johnson & Johnson, reflecting its strategic importance in addressing global health needs related to antiviral treatment.

NeoStrata Company, Inc., based in Princeton, New Jersey, specializes in developing and marketing a diverse range of clinically-proven dermatological products. Founded in 1988 by Drs. Van Scott and Yu, the company is known for its pioneering work with alpha hydroxy acids (AHAs) and polyhydroxy acids, which enhance skin rejuvenation and address various skin conditions. NeoStrata's product offerings include anti-aging systems, treatment cosmetics for skin imperfections, topical solutions for conditions like psoriasis, and products targeting issues such as acne, hyperpigmentation, and severe dry skin. The company provides cleansers, moisturizers, serums, and specialized kits through multiple channels, including consumer outlets, dermatologists, spas, and beauty retailers worldwide. It operates as a subsidiary of Johnson & Johnson Consumer Inc.

Inter-Grosshandel offers wide range of wholesale brand clothing

U.K.-based cardiovascular drug startup

Jagdale Industries Pvt Ltd(JIPL) is a part of the well-established and one-of-the-oldest industrial family group of Bengaluru: ‘The Jagdale family’. The roots of Jagdale go back to 1939 when Associated Drugs Company Ltd., was set up and to the contributions of Late Shri. Radhakrishna Jagdale, founder Jagdale group. JIPL has pioneered several products including unique food, beverage, nutraceutical and pharmaceutical formulations, in line with the nation’s needs and market requirements.

Alios BioPharma is focused on the discovery and development of innovative antiviral therapies aimed at treating both acute and chronic viral infections. The company employs a range of proprietary technologies, including small molecule activators that stimulate innate immunity, phosphate-protected nucleotide prodrug chemistry, and glycoprotein engineering of interferons. These complementary platforms enable the development of various therapeutic products targeting serious viral infections, such as chronic hepatitis B and C, HIV, respiratory viruses like pandemic influenza, and emerging viral diseases such as SARS. Alios BioPharma’s unique chemical library of nucleoside analogs and advanced virology-based screening systems further enhance its ability to create effective antiviral agents.

DePuy Synthes specializes in the manufacture of orthopedic and medtech equipment, focusing on healing and restoring movement for patients. Their extensive product range includes implants and biomaterials designed for surgical fixation and orthopedic procedures, covering areas such as joint reconstruction, trauma, craniomaxillofacial surgery, spinal surgery, and sports medicine. Key offerings include various surgical devices like clavicle plate systems, olecranon plates, anterior cervical interbody systems, and solutions for hip surgeries. Additionally, DePuy Synthes provides advanced services such as case management, loaner programs, and personalized solutions, enhancing the overall surgical experience and patient outcomes.

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

Elsker provides products to care for the skin health of babies. They provide body wash, shampoo, clothes, and talcum powder for babies. They also offer products for pregnant mothers.

Calibra Medical, Inc. develops medical devices and technologies in the diabetes sector. It offers insulin delivery devices. The company was formerly known as Seattle Medical Technologies, Inc. Calibra Medical, Inc. was founded in 2004 and is based in Redwood City, California.

SterilMed is a contracting manufacturer that produces medical devices. SterilMed reprocesses, remanufactures, and repairs medical devices and equipment.

Crucell N.V. is a global biopharmaceutical company dedicated to the research, development, production, and marketing of vaccines, proteins, and antibodies aimed at preventing and treating infectious diseases. The company offers a diverse portfolio of vaccines, including those for hepatitis B, a fully-liquid vaccine for five key childhood diseases, and a virosome-adjuvanted vaccine for influenza. Additionally, Crucell markets travel vaccines, featuring the only oral anti-typhoid vaccine, an oral cholera vaccine, and the sole aluminum-free hepatitis A vaccine available. Its products are distributed in both public and private markets worldwide, reflecting its commitment to combating infectious diseases through innovative solutions.

Micrus Endovascular Corporation develops and manufactures both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus Endovascular develops products that can be used by interventional neuroradiologists, interventional neurologists, and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. The Micrus Endovascular product lines enable physicians to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. It also sells stents, balloon catheters, access devices such as guide catheters, microcatheters, guidewires, and accessory products used in conjunction with its microcoils. Micrus Endovascular Corporation wasfounded in 1996 and is based in San Jose, California. As of September 27, 2010, Micrus Endovascular LLC operates as a subsidiary of Codman & Shurtleff, Inc.

Acclarent, Inc. is a medical device company focused on developing innovative technologies for ear, nose, and throat (ENT) patients. The company's primary emphasis is on balloon sinuplasty devices, which are minimally invasive tools designed to assist physicians in treating chronic sinusitis. These devices enable doctors to navigate the sinus anatomy and open blocked sinus ostia and passageways, facilitating sinus drainage. Acclarent's Balloon Sinuplasty technology and the Relieva product portfolio provide alternatives to conventional endoscopic surgical methods. The company received FDA clearances for its devices in 2005 and launched them commercially in the United States that same year, marking a significant advancement in sinus surgery.

Crucell N.V. is a global biopharmaceutical company dedicated to the research, development, production, and marketing of vaccines, proteins, and antibodies aimed at preventing and treating infectious diseases. The company offers a diverse portfolio of vaccines, including those for hepatitis B, a fully-liquid vaccine for five key childhood diseases, and a virosome-adjuvanted vaccine for influenza. Additionally, Crucell markets travel vaccines, featuring the only oral anti-typhoid vaccine, an oral cholera vaccine, and the sole aluminum-free hepatitis A vaccine available. Its products are distributed in both public and private markets worldwide, reflecting its commitment to combating infectious diseases through innovative solutions.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Founded in 1998, by Dr. Victor Strecher, HealthMedia® has developed a methodology and technology that effectively emulates a health coaching session, without the coach. Our one-of-a-kind programs possess the scalability of web content and deliver the efficacious outcomes a health coaching program receives.

Beijing Dabao Cosmetics Co., Ltd. is a manufacturer based in Beijing, China, specializing in herbal cosmetic products. The company is involved in the development, production, sale, and export of a diverse range of items, including face wash, moisturizers, sunscreens, shampoos, and various other skincare products. Dabao aims to cater to both domestic and international markets, focusing on the growing demand for herbal and natural cosmetics.

Conor MedSystems develops innovative controlled vascular drug delivery technologies. They have initially focused on the development of drug eluting stents to treat coronary artery disease.

InnerPulse, Inc. develops technology, devices, software protocols, and procedures to transform the treatment of cardiac arrhythmias. It offers invasive treatment that enables physicians to implant the life-saving Percutaneous Implantable Cardioverter Defibrillator within the patient's vascular system. InnerPulse, Inc. was formerly known as Interventional Rhythm Management, Inc.

CardioMEMS is a medical device company focused on the development and commercialization of proprietary wireless sensing and communication technology aimed at enhancing the management of severe chronic cardiovascular diseases, including heart failure, hypertension, and aneurysms. The company's innovative platform features miniature wireless sensors that can be implanted using minimally invasive techniques. These sensors transmit vital data, such as cardiac output, blood pressure, and heart rate, which are essential for effective patient management. By providing continuous monitoring, CardioMEMS' technology aims to improve patient outcomes and facilitate timely medical interventions.

Groupe Vendome SA manufactures adult and baby skin care products.

Peninsula Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the licensing, development, and commercialization anti-infective therapies for the treatment of patients with life-threatening infections for the North American and European markets. Peninsula's lead product candidate, doripenem, is a broad-spectrum antibiotic and a new member of the carbapenem class of beta-lactam antibiotics. Peninsula is currently evaluating doripenem in six Phase III clinical trials. In addition, doripenem received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of nosocomial pneumonia, including ventilator-associated pneumonia (VAP). Peninsula Pharmaceuticals was acquired by Johnson & Johnson, a global manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. Peninsula Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on developing and commercializing antibiotics to treat life-threatening infections.

Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules. Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005. The company was founded in 1998.

3-Dimensional Pharmaceuticals is a drug discovery company that develops advanced technologies to enhance and expedite the drug discovery process. By integrating high-throughput screening, combinatorial chemistry, and structure-based design, the company leverages genome sequencing targets to create efficient and innovative drug discovery solutions.

TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size.

Tibotec is a biopharmaceutical company focused on developing anti-viral treatments, with several promising compounds in development for the treatment of infectious diseases including HIV.

LXN Corporation is a medical technology company that develops, manufactures, and markets products to help people with diabetes better manage their disease. The company offers GlucoProtein, a home-based test that measures overall glucose control. It allows patients and healthcare professionals to better monitor the overall effectiveness of diabetes treatments and make timely and effective therapy changes. LXN Corporation was founded in 1994 and is based in San Diego, California.

BabyCenter, a subsidiary of Johnson & Johnson, is an online platform that offers comprehensive resources for parents and parents-to-be, covering topics related to conception, pregnancy, childbirth, and early childhood. The site provides free advice and tools, including a pregnancy calendar, baby name finder, due date calculator, and product recall finder, to assist users in navigating the various phases of parenthood. In addition to parenting guidance, BabyCenter features buying guides and product comparisons to aid parents in making informed purchasing decisions, along with an online store for direct merchandise purchases. The community aspect of BabyCenter is enhanced through interactive bulletin boards, chat sessions, and Q&A features, allowing expectant mothers to connect with peers and medical professionals. Recognized for its excellence, BabyCenter won the Best Family and Parenting Site at the 2006 Webby Awards.

SAND manufactures and sells financial POS machines.

MicroMass Communications is a marketing agency that specializes in healthcare communications, emphasizing evidence-based behavior change strategies to enhance patient health outcomes. Following the merger of SPS and MicroMass, it has emerged as one of the largest independent, full-service healthcare marketing and medical communications agencies in the Southeast. The agency provides a range of services, including patient engagement, relationship marketing, and health behavior consulting, tailored to the needs of pharmaceutical, medical device, and biotechnology companies in the United States. With a strong focus on understanding human health behavior and advocating for healthcare professionals, MicroMass aims to deliver effective solutions that resonate in the healthcare landscape.

Gynecare offers an endometrial ablation system for the treatment of uterine disorders. Gynecare offers devices like ThermaChoice Uterine Balloon Therapy system for the treatment of women who experience dysfunctional uterine bleeding. It also offers a VersaPoint Bipolar Electrosurgery system to treat women diagnosed with benign uterine pathologies including fibroids, polyps, adhesions, and divided septa.

Mitek Surgical Products provided bone anchors and minimally invasive surgical tools for orthopedic surgery. The company was founded by three Massachusetts Institute of Technology engineers in 1985.

Menlo Care, Inc. manufactures and markets vascular access and urological devices.